ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 80 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $141,000 | +131.1% | 21,811 | -41.8% | 0.02% | +114.3% |
| Q2 2020 | $61,000 | -16.4% | 37,447 | -3.3% | 0.01% | 0.0% |
| Q4 2019 | $73,000 | +23.7% | 38,710 | -28.6% | 0.01% | +40.0% |
| Q3 2019 | $59,000 | -67.8% | 54,181 | -35.1% | 0.01% | -54.5% |
| Q2 2019 | $183,000 | +161.4% | 83,539 | +610.5% | 0.01% | +175.0% |
| Q1 2019 | $70,000 | – | 11,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |